UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000017914
Receipt No. R000019949
Official scientific title of the study Comparison of PD and bile duct resection for middle bile duct cancer (Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?) Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery Biliary part
Date of disclosure of the study information 2015/07/01
Last modified on 2017/12/18 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Comparison of PD and bile duct resection for middle bile duct cancer
(Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?)
Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery
Biliary part
Title of the study (Brief title) Comparison of PD and bile duct resection for middle bile duct cancer
(Is additional-PD after bile duct segmental resection sufficient to surgical treatment for middle bile duct cancer?)
Japan-Korea Collaborative Research
Region
Japan Asia(except Japan)

Condition
Condition Middle bile duct cancer
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To compare the surgical outcomes of bile duct segmental resection (BDSR) and Pancreaticoduodenectomy (PD) for middle bile duct cancer

To verify whether the additional PD after BDSR to achieve negative bile duct margin have similar survival as straightforward PD.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes desease free survival
Key secondary outcomes Overall survival
R0 resection rate
Morbidity rate
Mortality rate
Recurrence rate
Site of Recurrence

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria -Middle bile duct cancer (definition of middle bile duct cancer is described above)

-Resected between 2001-2010

-Clinically T1, T2, T3 (without invasion to liver parenchyma by preoperative diagnostic imaging and intraoperative macroscopic findings) in TNM 7th classification (ICD-O C24.0) (cT1/2/3 but pT4 cancer should be included)

-M0

-Surgical strategies are defined as bile duct segmental resection (BDSR), pancreaticoduodenectomy including PD, PpPD and SSPPD (PD) and additional PD (AdPD).
Key exclusion criteria -Bismuth type I hilar cholangiocarcinoma

-cT4 cancer (With invasion to liver parenchyma by preoperative diagnostic imaging and intraoperative macroscopic findings) (cT1/2/3 but pT4 cancer should not be excluded)

-M1 desease

-Preoperative chemotherapy and/or radiation
-With hepatectomy (additional hepatectomy after BDSR or PD is excluded in this study)

-Patient with other cancer within 5-year


Target sample size 3600

Research contact person
Name of lead principal investigator Michiaki Unno
Organization Tohoku University Graduate School of Medicine
Division name Gastroenterology
Address 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan
TEL 022-717-7205
Email m_unno@surg1.med.tohoku.ac.jp

Public contact
Name of contact person Hiroki Hayashi
Organization Tohoku University Graduate School of Medicine
Division name Gastroenterology
Address 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan
TEL 022-717-7205
Homepage URL
Email hiroki@surg1.med.tohoku.ac.jp

Sponsor
Institute Japanese Ssociety of Hepato-Biliary-Pancreatic Surgery
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 01 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2015 Year 04 Month 01 Day
Anticipated trial start date
2015 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Biliary part of Japan-Korea Collaborative Research of Hepato-Biliary-Pancreatic Surgery

Biliary part

Management information
Registered date
2015 Year 06 Month 16 Day
Last modified on
2017 Year 12 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019949